Vertex Pharms Inc Drug Patent Portfolio

Vertex Pharms Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Vertex Pharms Inc News

Is it a good time to invest in Vertex Pharmaceuticals after a 10% decline?

07 Dec, 2025

Biotech Industry Surges: Encouraging Drug Trials Boost Investor Trust and Trigger Market Upswing

08 Nov, 2025

How Royalty Pharma Generates Revenue While Avoiding Major Biotech Risks - TradingView

01 Nov, 2025

Buyer's club to acquire affordable generic version of expensive Vertex cystic fibrosis medication - STAT News

24 Oct, 2025

See More